Dr. Suniti Mishra, who has joined the Sakra as Senior Consultant - Histopathology in the Department of Laboratory Medicine. She shall be reporting to the Director of Laboratory Medicine.
She has completed her MBBS and MD in pathology from Mahatma Gandhi Institute of Medical Sciences. She has done her FRCpath (Histopathology) from the Royal College of Pathologists, UK. With a special interest in Histopathology & Cytopathology, she did her Fellowship and Senior Residency in Onychopathology from the prestigious Tata Memorial Hospital, Mumbai. She has undergone special training in gastrointestinal pathology from CMC, Vellore, and in Neuropathology from NIMHANS, Bangalore.
Dr. Suniti has gained intensive experience of working in leading Corporate Hospitals in Bangalore for the last 20 years in Organisations like Manipal Hospital, Bangalore; Fortis Hospital SRL, Bangalore; and Sparsh Super speciality Hospital, Bangalore. She has developed rich skills through her special interests in the areas of gastrointestinal pathology, oncopathology & dermatopathology.
She has numerous publications to her credit in various reputed International and National journals on peritoneal malignancies & pseudomyxome peritonei. Dr. Suniti has won the distinguished Kunti Devi Award at the Annual Indian Association of Pathologists & microbiologists (IAPM) conference for Best original publication.
- Passed FRC path part 2 in October 2023 Royal College of Pathologists, United Kingdom.
- Passed FRC Path Part 1 in October 2022 Royal College of Pathologists, United Kingdom.
- M.D in Pathology, Nov 2003 Mahatma Gandhi Institute of Medical Sciences, Nagpur University.
- M.B.B.S, Nov 1997 Mahatma Gandhi Institute of Medical Sciences, Nagpur University.
- Senior Consultant Histopathologist and in charge, of histopathology at Sparsh Super Speciality Hospital Yeshwanthpur, Bangalore since Jan 2020.
- Managing Histopathology Laboratory (Leafbird Diagnostics) since June 2020.
- Senior consultant Pathologist at Fortis Hospital SRL since July 2016.
- Consultant Pathologist from August 2008 to June 2016 in the Department of Pathology, Manipal Hospital.
- Lecturer (Feb 2006-Jul 2008) Department of Pathology, St John’s Medical College and Hospital.
- Senior Resident (Oct 2005- Jan 2006) Department of Neuropathology, National Institute of Mental Health and Neurosciences (NIMHANS), Bangalore.
- Resident (Non-PG demonstrator) (March 2005 to June 2005) Department of Pathology, Christian Medical College, Vellore.
- Senior Registrar (March 2004- Feb 2005) Department of Surgical Pathology, Tata Memorial Hospital, Mumbai.
- Observer (Jan 2004- Feb 2004) Department of Hemato-Oncology, Tata Memorial Hospital, Mumbai.
- Accurate Handling of daily reporting especially in difficult cases as per expectations of Clinicians while complying with average Turnaround time.
- Leading end-to-end operations on a daily basis – Resource Management, Reporting, Escalations management, Process design, and compliance.
- Ensuring compliance of expected quality procedures and processes in the department as per the required standards (NABL, NABH, ISO, etc).
- Won the Kunti Devi Award in the Annual IAPM (Indian Association of Pathologists and Microbiologists) conference, for Best Original Publication for the year 2012-13.
- An immuno-histochemical comparison of expression of Bcl-2 as apoptotic and Mib-1 as proliferative markers in low and high grade ovarian serous carcinomas; International J Gynecologic Cancer 2010(4):537-541.
- Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site—a Review. Indian J Surg Oncol (2022). Bhatt, A., Mishra, S. & Glehen, O. https://doi.org/10.1007/s13193-022-01612-9.
- Distribution of residual disease in the peritoneum following neoadjuvant chemotherapy in advanced epithelial ovarian cancer and its potential therapeutic implications.
- Bhatt A, Bakrin N, Kammar P, Mehta S, Sinukumar S, Parikh L, Shaikh S, Mishra S, Mallaya M, Kepenekian V, Benzerdjeb N, Glehen O. Eur J Surg Oncol. 2021 Jan;47(1):181-187.
- Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide. Bhatt A, Mishra S, Parikh L, Sheth S, Gorur I. Indian J Surg Oncol. 2020 Mar;11(1):101-126.
- Target region resection in patients undergoing cytoreductive surgery for peritoneal metastases- is it necessary in the absence of visible disease? Bhatt A, Yonemura Y, Mehta S, Benzerdjeb N, Kammar P, Parikh L, Shah MY, Shaikh S, Prabhu A, Mishra S, Sinukumar S, Kepenekian V, Bakrin N, Passot G, Glehen O. Eur J Surg Oncol. 2020 Apr;46(4 Pt A):582-589.
- The Pathologic Peritoneal Cancer Index (PCI) Strongly Differs From the Surgical PCI in Peritoneal Metastases Arising From Various Primary Tumors.
- Bhatt A, Yonemura Y, Mehta S, Benzerdjeb N, Kammar P, Parikh L, Prabhu A, Mishra S, Shah M, Shaikh S, Kepenekian V, Bonnefoy I, Patel MD, Isaac S, Glehen O. Ann Surg Oncol. 2020 Aug;27(8):2985-2996.
- Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer- A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO).
- Pathological assessment of cytoreductive surgery specimens and its unexplored prognostic potential prospective multi-centric study. Bhatt A, Yonemura Y, Benzerdjeb N, Mehta S, Mishra S, Parikh L, Kammar P, Shah MY, Prabhu A, Shaikh S, Patel MD, Isaac S, Glehen O. Eur J Surg Oncol. 2019 Dec;45(12):2398-2404.
- Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Initial Experience from Indian Centers and a Review of Literature. Indian J Surg Oncol. 2019 Mar;10(1):24-30. doi: 10.1007/s13193-018-0771- 5. Epub 2018 May 16.
- Treading the beaten path with old and new obstacles: a report from the Indian HIPEC registry. Int J Hyperthermia. 2018;35(1):361-369. doi: 10.1080/02656736.2018.1503345. Epub 2018 Oct 9.
- Can low-grade PMP be divided into prognostically distinct subgroups based on histological features? A retrospective study and the importance of using the appropriate classification: European Journal of Surgical Oncology 44 (2018)1105-1111.
- Sequential cultivation of human epidermal keratinocytes and dermal mesenchymal-like stromal cells in vitro. Cytotechnology. 2016 Aug;68(4):1009-18. doi: 10.1007/s10616-015-9857. Epub 2015 Feb 20.
- Intraoperative Frozen Section Evaluation of Sentinel Lymph Nodes in Breast Carcinoma: Single Institution Indian Experience. Indian J Surg. 2015 Dec;77(Suppl 2):335-40. doi: 10.1007/s12262- 013-0827-2. Epub 2013 Feb 5.
- Anaplastic ependymoma; A rare brain tumor in a neonate: Journal of Clinical Neonatology; Oct 2015:4(4):265-267.
- Ovarian serous carcinoma; relationship of p53 and bcl-2 with tumor angiogenesis and VEGF expression. Int J Gynecol Pathol.2011.Nov30(6):521-6.
- An immuno-histochemical comparison of expression of Bcl-2 as apoptotic and Mib-1 as proliferative markers in low and high grade ovarian serous carcinomas; International J Gynecologic Cancer 2010(4):537-541.
- Significance of pre-operative thrombocytosis in epithelial ovarian cancer; Indian J pathology and microbiology; Jan2010:53(1);54-56.
- Primary Choriocarcinoma of the ovary-A case report.Journal of clinical and diagnostic research.2008 December;2(6):1207-09.
- Sinus Histiocytosis with massive lymphadenopathy- a review of 7 cases; Indian J Pathol Microbiol 2006;49(4);509-515.
